Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials ; volume:23 ; number:1 ; day:23 ; month:6 ; year:2022 ; pages:1-10 ; date:12.2022
BMC nephrology ; 23, Heft 1 (23.6.2022), 1-10, 12.2022
- Creator
-
Sapankaew, Tunlanut
Thadanipon, Kunlawat
Ruenroengbun, Narisa
Chaiyakittisopon, Kamolpat
Ingsathit, Atiporn
Numthavaj, Pawin
Chaiyakunapruk, Nathorn
McKay, Gareth
Attia, John
Thakkinstian, Ammarin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-022-02850-3
- URN
-
urn:nbn:de:101:1-2022081600032287538173
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sapankaew, Tunlanut
- Thadanipon, Kunlawat
- Ruenroengbun, Narisa
- Chaiyakittisopon, Kamolpat
- Ingsathit, Atiporn
- Numthavaj, Pawin
- Chaiyakunapruk, Nathorn
- McKay, Gareth
- Attia, John
- Thakkinstian, Ammarin
- SpringerLink (Online service)
Other Objects (12)
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Factors associated with initiation and persistence of urate-lowering therapy
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Selective amyloid-β lowering agents
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis
Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Factors associated with initiation and persistence of urate-lowering therapy
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Selective amyloid-β lowering agents
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis
Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Factors associated with initiation and persistence of urate-lowering therapy
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Selective amyloid-β lowering agents
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis